Using an INSM1-promoter luciferase screening platform, we identified 5′-IT, an adenosine kinase inhibitor, as a compound that suppresses INSM1 expression and inhibits NB cell growth, implicating adenosine metabolism and methionine cycle flux in INSM1 gene regulation. Here, ADK is linked to neuroblastoma.